Shoulder Innovations (NYSE:SI) Major Shareholder Healthcare Holding B.V. Gilde Sells 20,034 Shares of Stock

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 20,034 shares of the firm’s stock in a transaction dated Friday, July 31st. The shares were sold at an average price of $22.73, for a total transaction of $455,372.82. Following the transaction, the insider owned 2,332,203 shares of the company’s stock, valued at approximately $53,010,974.19. This trade represents a 0.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Stock Down 1.4%

SI stock opened at $22.41 on Tuesday. The firm has a market cap of $464.89 million and a PE ratio of -0.13. Shoulder Innovations, Inc. has a 12 month low of $10.92 and a 12 month high of $24.59. The company has a debt-to-equity ratio of 0.11, a current ratio of 11.81 and a quick ratio of 10.04. The firm has a 50 day simple moving average of $19.34 and a 200 day simple moving average of $15.86.

Shoulder Innovations (NYSE:SI) last posted its quarterly earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.44) by $0.03. Shoulder Innovations had a negative net margin of 81.78% and a negative return on equity of 35.11%. The firm had revenue of $16.71 million for the quarter. Equities research analysts forecast that Shoulder Innovations, Inc. will post -1.67 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the business. Deerfield Management Company L.P. acquired a new stake in shares of Shoulder Innovations during the third quarter worth approximately $6,056,000. Alyeska Investment Group L.P. acquired a new position in Shoulder Innovations in the 3rd quarter valued at approximately $5,667,000. Vanguard Group Inc. purchased a new stake in Shoulder Innovations in the 3rd quarter worth approximately $1,836,000. Roubaix Capital LLC boosted its stake in shares of Shoulder Innovations by 61.9% during the 1st quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock valued at $3,736,000 after buying an additional 98,305 shares during the period. Finally, Millennium Management LLC purchased a new position in shares of Shoulder Innovations during the 4th quarter valued at $1,316,000.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. UBS Group began coverage on Shoulder Innovations in a report on Tuesday, July 28th. They set a “buy” rating and a $27.00 target price for the company. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Shoulder Innovations in a research note on Monday, June 29th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $19.00 target price (up from $18.00) on shares of Shoulder Innovations in a report on Friday, May 8th. Six analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Shoulder Innovations presently has a consensus rating of “Moderate Buy” and a consensus target price of $22.00.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.